conference reporter

2021 Genitourinary Cancers Symposium

Conference Reporter in Metastatic Prostate Cancer to Cover Key Topics Being Presented at the 2021 Genitourinary Cancers Symposium

Overview

Conference Reporter delivers health care providers with insights from key thought leaders on exciting news presented at major medical conferences, in a concise and timely format. This issue of Conference Reporter will feature coverage of selected topics in Metastatic Prostate Cancer presented at this year’s 2021 Genitourinary Cancers Symposium.

The clinicians who were surveyed selected the following expert commentators and topics from the upcoming conference.

Community-Selected Expert Commentators: 

Peter R. Carroll, MD, MPH

Ken and Donna Derr – Chevron Distinguished Professor
Taube Family Distinguished Professor in Urology
Department of Urology
UCSF - Helen Diller Comprehensive Cancer Center
University of California, San Francisco
San Francisco, CA

E. David Crawford, MD

Professor of Urology
University of California, San Diego
Former, Distinguished Endowed Professor of Surgery, Urology, and Radiation Oncology
Head, Section of Urologic Oncology
University of Colorado Anschutz Medical Campus
Aurora, CO

William K. Oh, MD

Clinical Professor of Medicine
Division of Hematology and Medical Oncology
Icahn School of Medicine at Mount Sinai
New York, NY

Community-Selected Topics:

    Prostate-Specific Membrane Antigen–Targeted Therapies: Expert Insights
    High-Risk and Locally Advanced Prostate Cancer: Clinical Roundup
    Treatment Sequence in Patients With Metastatic Castration-Resistant Prostate Cancer
    Novel and Emerging Treatments for Progressive Metastatic Castration-Resistant Prostate Cancer
    Metastatic Prostate Cancer: Predictive Biomarkers for Tailored Treatment
    Progress on Treatment Personalization in Advanced Prostate Cancer


This information is brought to you by Engage Health Media and is not sponsored, endorsed, or accredited by the American Society of Clinical Oncology, the American Society for Radiation Oncology, or the Society of Urologic Oncology.

More in Metastatic Prostate Cancer

Thumb

Metastatic Prostate Cancer

Prostate-Specific Membrane Antigen–Targeted Therapies: Expert Insights

Conference Reporter by Peter R. Carroll, MD, MPH

Prostate-specific membrane antigen (PSMA) has emerged as a preeminent prostate cancer target for diagnostic imaging. Additionally, as seen at the 2...READ MORE

Thumb

Metastatic Prostate Cancer

High-Risk and Locally Advanced Prostate Cancer: Clinical Roundup

Conference Reporter by Peter R. Carroll, MD, MPH

Advancements in imaging and the identification of clinical and genomic risk factors are improving the treatment of patients with high-risk localize...READ MORE

Thumb

Metastatic Prostate Cancer

Treatment Sequence in Patients With Castration-Resistant Prostate Cancer

Conference Reporter by William K. Oh, MD

Strategies to sequence and combine therapies for patients with advanced prostate cancer continue to evolve as newer treatments emerge and data from...READ MORE

More In Conference Reporter

Metastatic Prostate Cancer

Promise in Treatment Personalization for Advanced Prostate Cancer

Conference Reporter
by E. David Crawford, MD

Metastatic Prostate Cancer

Metastatic Prostate Cancer: Predictive Biomarkers for Tailored Therapy

Conference Reporter
by E. David Crawford, MD

Metastatic Prostate Cancer

Novel and Emerging Treatments for Progressive Metastatic Castration-Resistant Prostate Cancer

Conference Reporter
by William K. Oh, MD